Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update on the U.S. launch of VYKATTM ...

However, a pocket rescission occurs whether the 45-day period spans the end of their period of the funds’ availability or if ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Attorneys and their clients are racing to submit opposition to the legal actions. In one case, the government sought to ...

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include ...

The brawl over redistricting is handing Gov. Gavin Newsom his biggest platform yet ahead of a likely presidential run in 2028 ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

A new chapter of regulations will eliminate the need for drone operators to secure waivers, a time-intensive and costly ...

President Trump said he would appoint a new commissioner of the Bureau of Labor Statistics “over the next three, four days.” ...

Your guide to federal funding cuts, plus resources for farmers and food businesses seeking support and solutions.

Completed Phase 3 enrollment for DURAVYU™ in wet AMD with over 800 patients enrolled and randomized -- LUGANO and LUCIA trials each rapidly enrolled in seven months underscoring strong physician and ...

Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core" or the "company") reported a net loss of $36.6 million, or $0.70 per diluted share, in the second quarter of 2025. Core reported adjusted ...